» Articles » PMID: 1847247

Development of a Short-term Inhalation Bioassay to Assess Pulmonary Toxicity of Inhaled Particles: Comparisons of Pulmonary Responses to Carbonyl Iron and Silica

Overview
Specialties Pharmacology
Toxicology
Date 1991 Feb 1
PMID 1847247
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

This paper describes a short-term inhalation bioassay for evaluating the lung toxicity of inhaled particulate materials. To validate the method, rats were exposed for 6 hr or 3 days to various concentrations of either aerosolized alpha-quartz silica or carbonyl iron particles. Cells and fluids from groups of sham- and dust-exposed animals were recovered by bronchoalveolar lavage (BAL). Alkaline phosphatase, lactate dehydrogenase (LDH), and protein values were measured in BAL fluids at several time points postexposure. Cells were identified, counted, and evaluated for viability. Pulmonary macrophages (PM) were cultured and studied for morphology, chemotaxis, and phagocytosis by scanning electron microscopy. The lungs of additional exposed animals were processed for histopathology and transmission electron microscopy. Brief exposures to silica elicited a sustained granulocytic inflammatory response (primarily neutrophils) with concomitant increases in alkaline phosphatase, LDH, and protein in the lavage fluids (p less than 0.05). In addition, PM functional capacity was depressed (p less than 0.05) and histopathologic lesions were observed within 1 month after exposure. In contrast, 6-hr or 3-day exposures to CI produced no cellular, cytotoxic, or alveolar/capillary membrane permeability changes at any time postexposure. PM function was either enhanced or unchanged from controls. These data demonstrate that short-term, high-dose inhalation exposures of silica produce effects similar to those previously observed using intratracheal instillation or chronic inhalation models, and lend support to this method as a reliable short-term bioassay for evaluating the pulmonary toxicity and mechanisms associated with exposures to new and untested materials.

Citing Articles

An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials.

Wiemann M, Vennemann A, Sauer U, Wiench K, Ma-Hock L, Landsiedel R J Nanobiotechnology. 2016; 14:16.

PMID: 26944705 PMC: 4779246. DOI: 10.1186/s12951-016-0164-2.


Rifapentine-proliposomes for inhalation: in vitro and in vivo toxicity.

Patil-Gadhe A, Kyadarkunte A, Pereira M, Jejurikar G, Patole M, Risbud A Toxicol Int. 2015; 21(3):275-82.

PMID: 25948966 PMC: 4413410. DOI: 10.4103/0971-6580.155361.


Acute pulmonary toxicity and body distribution of inhaled metallic silver nanoparticles.

Kwon J, Minai-Tehrani A, Hwang S, Kim J, Shin J, Yu K Toxicol Res. 2013; 28(1):25-31.

PMID: 24278586 PMC: 3834404. DOI: 10.5487/TR.2012.28.1.025.


Pulmonary toxicity screening studies in male rats with TiO2 particulates substantially encapsulated with pyrogenically deposited, amorphous silica.

Warheit D, Webb T, Reed K Part Fibre Toxicol. 2006; 3:3.

PMID: 16438714 PMC: 1402317. DOI: 10.1186/1743-8977-3-3.


Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy.

Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K Part Fibre Toxicol. 2005; 2:8.

PMID: 16209704 PMC: 1260029. DOI: 10.1186/1743-8977-2-8.